Stem Cell Therapeutic and Research Reauthorization Act of 2025
H.R. 5160
This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA).
Learn about this bill’s status and read its full summary in the Pocket Congress app.
Open in the Pocket Congress app 
Scan to open this page in Pocket Congress